JP2024542128A5 - - Google Patents

Info

Publication number
JP2024542128A5
JP2024542128A5 JP2024526803A JP2024526803A JP2024542128A5 JP 2024542128 A5 JP2024542128 A5 JP 2024542128A5 JP 2024526803 A JP2024526803 A JP 2024526803A JP 2024526803 A JP2024526803 A JP 2024526803A JP 2024542128 A5 JP2024542128 A5 JP 2024542128A5
Authority
JP
Japan
Prior art keywords
diseases
alkyl
aryl
cycloalkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024542128A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/049091 external-priority patent/WO2023081441A1/en
Publication of JP2024542128A publication Critical patent/JP2024542128A/ja
Publication of JP2024542128A5 publication Critical patent/JP2024542128A5/ja
Pending legal-status Critical Current

Links

JP2024526803A 2021-11-08 2022-11-07 ヘテロ環式化合物およびその使用 Pending JP2024542128A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163276927P 2021-11-08 2021-11-08
US63/276,927 2021-11-08
PCT/US2022/049091 WO2023081441A1 (en) 2021-11-08 2022-11-07 Heterocyclic compounds and uses thereof

Publications (2)

Publication Number Publication Date
JP2024542128A JP2024542128A (ja) 2024-11-13
JP2024542128A5 true JP2024542128A5 (cg-RX-API-DMAC7.html) 2026-01-23

Family

ID=84980842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526803A Pending JP2024542128A (ja) 2021-11-08 2022-11-07 ヘテロ環式化合物およびその使用

Country Status (8)

Country Link
US (1) US20250002487A1 (cg-RX-API-DMAC7.html)
EP (2) EP4778593A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024542128A (cg-RX-API-DMAC7.html)
CN (1) CN118201924A (cg-RX-API-DMAC7.html)
AU (1) AU2022383051A1 (cg-RX-API-DMAC7.html)
CA (1) CA3236877A1 (cg-RX-API-DMAC7.html)
TW (1) TW202340181A (cg-RX-API-DMAC7.html)
WO (1) WO2023081441A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4638446A1 (en) * 2022-12-20 2025-10-29 Ventus Therapeutics U.S., Inc. Thiadiazole derivatives as inhibitors of cyclic gmp-amp synthase and uses thereof
WO2024233767A1 (en) * 2023-05-10 2024-11-14 Ventus Therapeutics U.S., Inc. Inhibitors of cyclic gmp-amp synthase and uses thereof
EP4652164A1 (en) * 2023-05-10 2025-11-26 Ventus Therapeutics U.S., Inc. Inhibitors of cyclic gmp-amp synthase and uses thereof
AR133584A1 (es) 2023-08-18 2025-10-15 Univ Leuven Kath Nuevos compuestos
WO2026077404A1 (zh) * 2024-10-10 2026-04-16 北京知维拓医药科技有限公司 一种杂环类化合物及其用途
WO2026130575A1 (zh) * 2024-12-20 2026-06-25 杭州英创医药科技有限公司 cGAS抑制剂
WO2026158338A1 (zh) * 2025-01-22 2026-07-30 北京知维拓医药科技有限公司 一种杂环类化合物及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262564A (en) 1992-10-30 1993-11-16 Octamer, Inc. Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
CN1665808A (zh) * 2002-05-06 2005-09-07 沃泰克斯药物股份有限公司 噻二唑或噁二唑及其作为jak蛋白激酶抑制剂的用途
JP2016506408A (ja) 2012-12-19 2016-03-03 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム 哺乳動物の環状ジヌクレオチドシグナル伝達経路の薬学的標的化
JP6896701B2 (ja) * 2016-02-26 2021-06-30 大日本住友製薬株式会社 イミダゾリルアミド誘導体
EP3700527A4 (en) * 2017-10-25 2021-03-10 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHOD OF USING THEM
MX2020008237A (es) 2018-02-05 2020-09-25 Univ Rockefeller Inhibidores de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol de cgas para tratar enfermedades autoinflamatorias.
WO2020072492A1 (en) * 2018-10-02 2020-04-09 Baruch S. Blumberg Institute Benzamide derivatives as cgas-sting pathway agonists
WO2020077361A1 (en) * 2018-10-12 2020-04-16 The General Hospital Corporation Compounds and methods of their use
US20230242494A1 (en) * 2020-05-20 2023-08-03 Hoffmann-La Roche Inc. Malonitrile derivatives

Similar Documents

Publication Publication Date Title
JP2024520481A5 (cg-RX-API-DMAC7.html)
JP2023520333A5 (cg-RX-API-DMAC7.html)
JP2021529812A5 (cg-RX-API-DMAC7.html)
JP2022520448A5 (cg-RX-API-DMAC7.html)
JP2019518766A5 (cg-RX-API-DMAC7.html)
JP2023536164A5 (cg-RX-API-DMAC7.html)
JP2023531709A5 (cg-RX-API-DMAC7.html)
JP2011509309A5 (cg-RX-API-DMAC7.html)
JP7182304B2 (ja) インドリノン化合物の使用
JP2019094345A5 (cg-RX-API-DMAC7.html)
JP2023533203A5 (cg-RX-API-DMAC7.html)
JP2021535207A5 (cg-RX-API-DMAC7.html)
RU2015107803A (ru) Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания
JP2020505395A5 (cg-RX-API-DMAC7.html)
RU2007146798A (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
JP2022521746A5 (cg-RX-API-DMAC7.html)
JP2019517487A5 (cg-RX-API-DMAC7.html)
RU2013154412A (ru) Аминопиримидины в качестве ингибиторов syc
JP2016506959A5 (cg-RX-API-DMAC7.html)
JP2021535112A5 (cg-RX-API-DMAC7.html)
JP2023531495A5 (cg-RX-API-DMAC7.html)
RU2019141734A (ru) Терапевтические соединения и композиции и способы их применения
JP2019507114A5 (cg-RX-API-DMAC7.html)
JP2025508323A5 (cg-RX-API-DMAC7.html)
JP2021535213A5 (cg-RX-API-DMAC7.html)